AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Dare Bioscience, Inc. Director's Dealing 2015

Jun 30, 2015

34825_dirs_2015-06-30_f3879217-cf4d-4753-9a28-2dc1c424df54.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-06-26

Reporting Person: Arbuckle Stuart A (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned.	0	Direct